Position in BMY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$621,676,934
+$250,598,054 QoQ
Shares Held
10,250,238
+49.0% QoQ
Ownership
0.502%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.73807944752112.ToString("F0")%
Shared 0.ToString("F0")%
None 4.261920552478879.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $32,740,779,918 across 15 Drug Manufacturers - General names. BMY ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,992,224 | $12,869,627,867 | |
| 2 | JNJ |
Johnson & Johnson
|
16,491,133 | $4,031,092,550 | |
| 3 | AZN |
Astrazeneca PLC
|
19,489,220 | $3,843,663,968 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
26,248,108 | $3,658,198,811 | |
| 5 | ABBV |
AbbVie Inc.
|
13,003,989 | $2,828,237,567 | |
| 6 | MRK |
Merck & Co., Inc.
|
23,042,842 | $2,771,823,463 | |
| 7 | AMGN |
Amgen Inc
|
1,867,189 | $656,970,449 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
10,250,238 | $621,676,934 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $621,676,934 | 10,250,238 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $371,078,880 | 6,879,475 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $348,131,274 | 7,719,097 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $336,695,637 | 7,273,615 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $353,094,041 | 5,789,376 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $425,778,645 | 7,527,911 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,047,206,371 | 20,239,783 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $635,424,406 | 15,300,371 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $680,468,440 | 12,547,823 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $363,585,533 | 7,086,056 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $387,955,204 | 6,684,273 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $391,996,936 | 6,129,741 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $485,711,934 | 7,007,819 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $532,246,814 | 7,397,454 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $432,617,767 | 6,085,494 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,123,200,771 | 14,587,023 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,154,112,662 | 15,803,268 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $209,371,549 | 3,358,004 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $230,715,604 | 3,899,199 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $238,783,875 | 3,573,539 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $229,126,799 | 3,629,444 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $244,094,190 | 3,935,099 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $414,628,859 | 6,877,241 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $508,235,742 | 8,643,465 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $540,390,381 | 9,694,840 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||